Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grace Mathew

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Pediatric Hematology and Oncology|July 21, 2023
What happens to children with acute lymphoblastic leukemia in low- and middle-income countries after relapse? A single-center experience from IndiaRicha Sharon Angel Korrapolu, Deepthi Boddu, Rikki John, et al.
NPJ Precision Oncology|October 28, 2021
An analysis of research biopsy core variability from over 5000 prospectively collected core samplesDeepak Bhamidipati, Anuj Verma, Dawen Sui, et al.
Nature Cancer|February 13, 2024
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcomaChristina L Roland, Elise F Nassif Haddad, Emily Z Keung, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Pediatric Hematology and Oncology|July 21, 2023
What happens to children with acute lymphoblastic leukemia in low- and middle-income countries after relapse? A single-center experience from IndiaRicha Sharon Angel Korrapolu, Deepthi Boddu, Rikki John, et al.
NPJ Precision Oncology|October 28, 2021
An analysis of research biopsy core variability from over 5000 prospectively collected core samplesDeepak Bhamidipati, Anuj Verma, Dawen Sui, et al.
Nature Cancer|February 13, 2024
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcomaChristina L Roland, Elise F Nassif Haddad, Emily Z Keung, et al.
Pageof 4